Assort Health, a San Francisco, CA-based patient experience platform powered by specialty-specific agentic AI, has secured $76 million in Series B funding.
Investors
The round was led by Lightspeed Venture Partners, with participation from Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations across the enterprise, consumer, fintech, and health sectors. With $25 billion in AUM, it has backed over 500 companies globally over two decades, with teams across the U.S., Europe, India, Israel, and Southeast Asia.
Assort Health Use of Funds
The company will use the funding to grow its team and advance its AI-powered operating system.
About Assort Health
Founded by Jeff Liu and Jon Wang, Assort Health is a healthcare technology company that provides a patient experience platform powered by specialty-specific agentic AI. It is designed to manage patient phone calls and communications for healthcare organizations. The company’s platform, Assort OS, integrates with EHR and practice management workflows to automate and enhance patient interactions from scheduling and care navigation to lab coordination and prescription renewals. Headquartered in San Francisco, California, Assort Health serves healthcare organizations, including OrthoIndy and Chesapeake Healthcare.
Funding Details
Company: Assort Health, Inc.
Raised: $76.0M
Round: Series B
Funding Date: September 2025
Lead Investor: Lightspeed Venture Partners
Additional Investors: Felicis, First Round Capital, Chemistry, A*, Liquid2, Quiet Capital
Company Website: https://www.assorthealth.com/
Software Category: HealthTech / AI / Patient Experience Platform
Source: https://www.prnewswire.com/news-releases/assort-health-secures-102-million-to-scale-nations-first-agentic-ai-platform-that-solves-longstanding-frustrations-tied-to-patient-access-and-experience-302570046.html